[The influence of chloroquine on some biochemical and hematological parameters in patients with critical limb

P Mondek1, R Slysko, V Sefránek

  • 1Klinika cievnej chirurgie, Slovensý ústav srdcových a cievnych chorôb, Bratislava, Slovenská republika. mondo@pobox.sk

Insights

Critical limb ischemia (CLI) is a growing health issue. This study monitored hematological markers during reperfusion, investigating neutrophil-lymphocyte ratio and PMNL elastase to assess CLI severity.

Area of Science:

  • Hematology
  • Biochemistry
  • Clinical Medicine

Context:

  • Critical limb ischemia (CLI) presents a significant and escalating medical and social challenge.
  • Estimated incidence of CLI ranges from 500 to 1000 cases per million inhabitants.
  • Monitoring hematological and biochemical markers during reperfusion is crucial for managing CLI.

Purpose:

  • To monitor key hematological and biochemical markers during reperfusion in patients with critical limb ischemia (CLI).
  • To investigate the potential for medical intervention to influence polymorphonuclear neutrophil (PMNL) elastase levels.
  • To evaluate the neutrophil-lymphocyte ratio (NLR) as a reliable indicator of clinical severity in CLI patients.

Summary:

  • A clinical study conducted between 2000 and 2004 focused on patients with CLI undergoing reperfusion.
  • The study monitored specific hematological and biochemical markers, including PMNL elastase and the NLR.
  • The neutrophil-lymphocyte ratio was assessed for its utility in gauging the severity of the clinical condition.

Impact:

  • Provides insights into hematological and biochemical changes during CLI reperfusion.
  • Highlights the potential role of PMNL elastase modulation in CLI management.
  • Establishes the neutrophil-lymphocyte ratio as a simple and reliable marker for assessing CLI severity.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...